Literature DB >> 19581272

Multislice computed tomography coronary angiography for risk stratification in patients with an intermediate pretest likelihood.

J M van Werkhoven1, O Gaemperli, J D Schuijf, J W Jukema, L J Kroft, S Leschka, H Alkadhi, I Valenta, G Pundziute, A de Roos, E E van der Wall, P A Kaufmann, J J Bax.   

Abstract

OBJECTIVES: To assess whether multislice computed tomography coronary angiography (MSCTA) may be useful for risk stratification of patients with suspected coronary artery disease (CAD) at intermediate pretest likelihood according to Diamond and Forrester. DESIGN AND PATIENTS: MSCTA images were evaluated for the presence of significant CAD in 316 patients with suspected CAD (60% male, average (SD) age 57 (11) years) and an intermediate pretest likelihood according to Diamond and Forrester. Patients were followed up to determine the occurrence of an event. MAIN OUTCOME MEASURES: A combined end point of all-cause mortality, non-fatal infarction and unstable angina requiring revascularisation.
RESULTS: Significant CAD was seen in 89 patients (28%), whereas normal MSCTA or non-significant CAD was seen in the remaining 227 (72%) patients. During follow-up (median 621 days (25-75th centile 408-835) an event occurred in 13 patients (4.8%). The annualised event rate was 0.8% in patients with normal MSCT, 2.2% in patients with non-significant CAD and 6.5% in patients with significant CAD. Moreover, MSCTA remained a significant predictor (p<0.05) of events after multivariate correction (hazard ratio = 3.460 (95% CI 1.142 to 10.480).
CONCLUSIONS: The results suggest that in patients with an intermediate pretest likelihood, MSCTA is highly effective in re-stratifying patients into either a low or high post-test risk group. These results further emphasise the usefulness of non-invasive imaging with MSCTA in this patient population.

Entities:  

Mesh:

Year:  2009        PMID: 19581272     DOI: 10.1136/hrt.2009.167353

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  16 in total

Review 1.  Coronary CT angiography: Beyond morphological stenosis analysis.

Authors:  Zhonghua Sun
Journal:  World J Cardiol       Date:  2013-12-26

2.  Statins for primary prevention: problems with cardiovascular-risk estimation?

Authors:  Željko Reiner
Journal:  Nat Rev Cardiol       Date:  2013-07-23       Impact factor: 32.419

Review 3.  Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis.

Authors:  Anne Grete Semb; Eirik Ikdahl; Grunde Wibetoe; Cynthia Crowson; Silvia Rollefstad
Journal:  Nat Rev Rheumatol       Date:  2020-06-03       Impact factor: 20.543

4.  Prognostic value of CT angiography for major adverse cardiac events in patients with acute chest pain from the emergency department: 2-year outcomes of the ROMICAT trial.

Authors:  Christopher L Schlett; Dahlia Banerji; Emily Siegel; Fabian Bamberg; Sam J Lehman; Maros Ferencik; Thomas J Brady; John T Nagurney; Udo Hoffmann; Quynh A Truong
Journal:  JACC Cardiovasc Imaging       Date:  2011-05

5.  Computed tomography coronary angiography in the selection of outlier patients: a feasibility report.

Authors:  E Maffei; C Martini; S Seitun; T Arcadi; C Tedeschi; A Guaricci; R Malagò; G Tarantini; A Aldrovandi; F Cademartiri
Journal:  Radiol Med       Date:  2011-06-04       Impact factor: 3.469

6.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

7.  Prognostic value of coronary CT angiography on long-term follow-up of 6.9 years.

Authors:  Svetlana Dougoud; Tobias A Fuchs; Julia Stehli; Olivier F Clerc; Ronny R Buechel; Bernhard A Herzog; Sebastian Leschka; Hatem Alkadhi; Philipp A Kaufmann; Oliver Gaemperli
Journal:  Int J Cardiovasc Imaging       Date:  2014-04-08       Impact factor: 2.357

8.  Effect of smoking status on coronary artery disease among Chinese post-menopausal women.

Authors:  Jinling Ma; Xiujie Wang; Meng Gao; Yu Ding; Yadong Guan
Journal:  Intern Emerg Med       Date:  2015-10-26       Impact factor: 3.397

9.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

10.  European guidelines on cardiovascular disease prevention in clinical practice (version 2012) : the fifth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; W M Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte Op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Int J Behav Med       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.